Benefit/risk Ratio of Low-dose Methotrexate in Cutaneous Lesions of Mycosis Fungoides and Sézary Syndrome.

Acta Derm Venereol · 2021 · PMC9366701 · PMID 33313939

Europe PMC DOI

hedged sentence

0.0670

closest p · 1.3× alpha

0.0670

boldest claim

The sentences

a trend toward significancep = 0.067so close (0.05 < p ≤ 0.1)

Overall response rate (ORR) was not significantly different between MF and SS (70% (21/30) vs 77.7% (14/18), respectively, p = 0.28), but CR was more frequently obtained in MF (CR 30%/PR 40%) than in SS (CR 5.5%/PR 72.2%), with a trend toward significance ( p = 0.067).

also in 3,729 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.